The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. This year’s metric has recorded a Price decrease of -82.21%. However, over the past six months, we’ve seen a stronger performance of -68.29%. The price of CMMB leaped by -32.24% over the last 30 days. And in the last five days, it has fallen by -3.53%.
Currently, the stock price of Chemomab Therapeutics Ltd ADR (CMMB) is $0.57. In the most recent trading session, the stock underwent a significant upswing, peaking at $0.6399 after opening at $0.6018. The stock touched a low of $0.525 before closing at $0.66.
The stock market performance of Chemomab Therapeutics Ltd ADR has been fairly unsteady. Over the last year, the company’s stock hit its highest at $5.35 on 01/03/23, while the lowest price during the same time frame was $0.50, recorded on 11/09/23.
52-week price history of CMMB Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Chemomab Therapeutics Ltd ADR’s current trading price is -89.36% away from its 52-week high, while its distance from the 52-week low is 13.84%. The stock’s price range for this period has been between $0.50 and $5.35. The Healthcare sector company’s shares saw a trading volume of about 1.01 million for the day, which was lower than the average daily volume of 1.24 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Chemomab Therapeutics Ltd ADR (CMMB) has experienced a quarterly decline of -47.78% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 7.06M and boasts a workforce of 37 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.0327, with a change in price of -0.6515. Similarly, Chemomab Therapeutics Ltd ADR recorded 824,683 in trading volume during the last 100 days, posting a change of -53.37%.
CMMB’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for CMMB stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.
CMMB Stock Stochastic Average
As of today, the raw stochastic average of Chemomab Therapeutics Ltd ADR over the past 50 days is 11.35%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 11.93%. Additionally, the Stochastic %K and %D values for the company were 31.39% and 33.78%, respectively, over the past 20 days.